Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-03-04
1995-01-17
Tsang, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544369, A61K 31495, C07D41306, C07D41706
Patent
active
053825845
ABSTRACT:
A series of 1-piperazinyl-N-phenylacetamide derivatives of 4,5-diphenyl-oxazoles, thiazoles, and imidazoles which are novel adenosine transport inhibitors have been found to provide effective antiischemic protection for CNS and cardiac tissue, particularly neurons. A method of treatment to protect against CNS ischemia, such as that resulting from trauma, stroke, or other ischemic conditions, comprises administration of these novel compounds to an individual in need of such treatment.
REFERENCES:
patent: 3267104 (1966-08-01), Hermans et al.
patent: 4020082 (1977-04-01), Marchetti
patent: 4101660 (1978-07-01), Inoue et al.
patent: 4766125 (1988-08-01), Van Daele
patent: 4948796 (1990-08-01), Hiraiwa et al.
Inoue et al, "2-Aminomethyl-5-phenyloxazoles", Chemical Abstracts, vol. 91 (1979), pp. 707, paragraph: 91:56986x.
Inoue et al, "2-Aminomethyl-5-phenyloxazoles", Chemical Abstracts, vol. 91 (1979), pp. 707-708, paragraph: 91:56987y.
Bristol--Myers Squibb Company
Ryan Richard P.
Tsang Cecilia
LandOfFree
Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles,, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-747227